Chemotherapy and Drug Information
[Translational Lung Cancer Research] In this article, the authors examine the role of adjuvant chemotherapy in the treatment of resected non-small cell lung cancer.
The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to new study data.
Research suggests supplements, and certain fish, might reduce the effects of chemotherapy.
Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer (NSCLC) showed better overall survival when treated at experienced facilities.
A subset of adrenal cancer patients responded well to drug treatment in a phase 3 trial, giving some hope for addressing this aggressive form of cancer.
Findings of a 7-year study revolutionized the standard protocol for patient management by reducing toxicities for patients with metastatic renal cell carcinoma (mRCC).
A new study of the impact of exercise in models of breast cancer in mice has shown the benefits of exercise on the function of blood vessels around tumors.
Why do some drugs need a micron filter and what is the affect of using one?
A measurement of the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy may allow for better matching of patients to the optimal intensity of chemotherapy.
Breast cancer patients given the hormone-blocking drug goserelin during chemotherapy experience less ovarian failure and are more likely to have successful pregnancies, according to study results.
Stat Consult Slideshows
This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the pancreas; also adjuvant treatment of colorectal cancer.
This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.
This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.
To view all content in our Stat Consult section, please click here.
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Muscle-building supplements may be associated with testicular cancer
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Promising drug target identified in medulloblastoma
- Physical activity associated with less chemo-induced peripheral neuropathy
- mHealth app assesses breast cancer risk and aids prevention
- Socioeconomic factors increase mortality after lung cancer surgery
- Half of older U.S. adults take aspirin as preventive medicine
- Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
- Adjuvant chemotherapy in non-small cell lung cancer: State-of-the-art
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|